ERCC1 and cervical cancer: (24) reported that uterine cervix cancer patients with low ERCC1 expression had significantly worse OS (17.9% vs. 50.1%, P = 0.046) and worse DFS (21.4% vs. 47.4%, P= 0.083) than those with higher expression levels.